Dongsoo Ham

Title: The Innovations of Dongsoo Ham

Introduction

Dongsoo Ham is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of medical science, particularly in the development of pneumococcal vaccines. With a total of five patents to his name, his work has the potential to impact public health positively.

Latest Patents

Dongsoo Ham's latest patents include a multivalent pneumococcal polysaccharide-protein conjugate composition. This invention provides mixed carrier, multivalent pneumococcal conjugate compositions comprising 21 different pneumococcal capsular polysaccharide-protein conjugates. Each conjugate includes a capsular polysaccharide from a different serotype conjugated to either tetanus toxoid or CRM. The serotypes selected for this composition include 1, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F. The invention also outlines methods for producing these compositions and their use for prophylaxis against infection or disease in subjects.

Career Highlights

Throughout his career, Dongsoo Ham has worked with notable companies such as Sanofi Pasteur Inc. and SK Bioscience Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in vaccine development.

Collaborations

Dongsoo Ham has collaborated with several professionals in his field, including Kyungjun An and Hun Rae Kim. These collaborations have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Dongsoo Ham's contributions to the field of pneumococcal vaccine development highlight his role as an influential inventor. His innovative work continues to pave the way for advancements in medical science and public health.